Wednesday, December 6, 2017

PFO Closure for Migraine: Debates Continue as PREMIUM Published

Patient subgroups may benefit, suggest some findings from the sham-controlled trial, at least the third major study of the controversial procedure. Further studies are warranted, says an observer.

No comments:

Post a Comment